XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(Q1)Dec 31, 2024 | (FY)Sep 30, 2024 | (Q4)Sep 30, 2024 | (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 15.30%201.43M | 20.63%732.69M | 15.30%196.36M | 15.77%177.46M | 12.43%184.18M | 45.57%174.7M | 45.05%607.41M | 53.92%170.3M | 51.82%153.29M | 60.47%163.82M |
Operating revenue | 15.30%201.43M | 20.63%732.69M | 15.30%196.36M | 15.77%177.46M | 12.43%184.18M | 45.57%174.7M | 45.05%607.41M | 53.92%170.3M | 51.82%153.29M | 60.47%163.82M |
Cost of revenue | 8.37%100.14M | 16.57%384.53M | 6.66%99.36M | 7.81%95.28M | 12.15%97.49M | 50.48%92.41M | 59.18%329.87M | 63.70%93.16M | 66.07%88.38M | 76.65%86.93M |
Gross profit | 23.09%101.29M | 25.45%348.16M | 25.74%97M | 26.61%82.18M | 12.74%86.69M | 40.43%82.29M | 31.20%277.54M | 43.57%77.14M | 35.94%64.91M | 45.41%76.89M |
Operating expense | 8.46%73.81M | 12.93%289.27M | 6.25%70.98M | 16.33%74.74M | 6.42%75.5M | 25.68%68.06M | 35.41%256.14M | 32.90%66.8M | 40.29%64.25M | 43.32%70.94M |
Selling and administrative expenses | 8.46%73.81M | 12.93%289.27M | 6.25%70.98M | 16.33%74.74M | 6.42%75.5M | 25.68%68.06M | 35.41%256.14M | 32.90%66.8M | 40.29%64.25M | 43.32%70.94M |
-Selling and marketing expense | 9.17%21.23M | 8.44%78.26M | 2.95%18.24M | 1.49%19.42M | 2.27%21.15M | 32.92%19.45M | --72.17M | --17.72M | 37.42%19.14M | 42.93%20.68M |
-General and administrative expense | 8.17%52.58M | 14.69%211.01M | 7.45%52.74M | 22.62%55.31M | 8.13%54.35M | 23.00%48.61M | --183.97M | --49.08M | 41.54%45.11M | 43.47%50.26M |
Operating profit | 93.09%27.48M | 175.20%58.89M | 151.69%26.02M | 1,023.08%7.45M | 88.13%11.19M | 219.94%14.23M | -4.36%21.4M | 198.38%10.34M | -66.07%663K | 76.16%5.95M |
Net non-operating interest income expense | 109.60%86K | 16.81%-3.16M | 23.41%-795K | 46.49%-709K | 9.01%-757K | -49.33%-896K | -153.85%-3.8M | -212.65%-1.04M | -173.76%-1.33M | -81.66%-832K |
Non-operating interest income | -10.94%1.76M | 7.73%6.31M | -8.06%1.47M | -11.76%1.44M | -20.94%1.43M | 139.98%1.98M | 1,056.02%5.86M | 282.10%1.6M | 2,300.00%1.63M | 22,462.50%1.81M |
Non-operating interest expense | -41.73%1.67M | -1.92%9.47M | -14.10%2.27M | -27.32%2.15M | -17.18%2.18M | 101.76%2.87M | 382.32%9.66M | 251.40%2.64M | 435.69%2.96M | 465.88%2.64M |
Other net income (expense) | -116.36%-35K | 2.69%496K | 350.88%143K | -77.53%20K | -5.56%119K | -34.15%214K | 210.27%483K | 44.12%-57K | 130.58%89K | 177.30%126K |
Other non- operating income (expenses) | -116.36%-35K | 2.69%496K | 350.88%143K | -77.53%20K | -5.56%119K | -34.15%214K | 210.27%483K | 44.12%-57K | 130.58%89K | 177.30%126K |
Income before tax | 103.18%27.53M | 210.89%56.23M | 174.45%25.37M | 1,279.23%6.76M | 101.30%10.55M | 224.68%13.55M | -11.52%18.09M | 204.98%9.24M | -148.60%-573K | 90.24%5.24M |
Income tax | 70.13%5.38M | 146.82%14.23M | 156.99%6.53M | 2,868.75%1.77M | 56.95%2.77M | 107.21%3.16M | 206.62%5.77M | 1,157.92%2.54M | -119.05%-64K | 138.34%1.76M |
Net income | 113.24%22.15M | 240.86%42M | 181.07%18.84M | 1,079.37%4.99M | 123.76%7.79M | 292.33%10.39M | -52.33%12.32M | 136.94%6.7M | -160.38%-509K | -52.68%3.48M |
Net income continuous Operations | 113.24%22.15M | 240.86%42M | 181.07%18.84M | 1,079.37%4.99M | 123.76%7.79M | 292.33%10.39M | -52.33%12.32M | 136.94%6.7M | -160.38%-509K | -52.68%3.48M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 113.24%22.15M | 240.86%42M | 181.07%18.84M | 1,079.37%4.99M | 123.76%7.79M | 292.33%10.39M | -52.33%12.32M | 136.94%6.7M | -160.38%-509K | -52.68%3.48M |
Preferred stock dividends | -78.36%1.1M | 0 | -14.10%1.1M | -1.74%5.07M | 2.57%1.28M | -2.55%1.26M | -3.32%1.25M | |||
Other preferred stock dividends | 0 | 5.27%2.86M | 0 | 0 | 0 | 455.45%2.86M | -65.44%2.71M | 252.70%2.03M | 0 | -64.69%833K |
Net income attributable to common stockholders | 244.15%22.15M | 737.90%38.05M | 454.61%18.84M | 381.32%4.99M | 457.81%7.79M | 651.11%6.44M | -64.64%4.54M | 237.00%3.4M | -291.17%-1.77M | -62.28%1.4M |
Basic earnings per share | 127.78%0.41 | 492.31%0.77 | 250.00%0.35 | 280.00%0.09 | 250.00%0.14 | 500.00%0.18 | -66.67%0.13 | 233.33%0.1 | -400.00%-0.05 | -63.64%0.04 |
Diluted earnings per share | 135.29%0.4 | 476.92%0.75 | 240.00%0.34 | 280.00%0.09 | 250.00%0.14 | 750.00%0.17 | -65.79%0.13 | 233.33%0.1 | -400.00%-0.05 | -63.64%0.04 |
Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |